ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2020.0.247 2020.0.247 2021-06-302021-06-3011132020-04-01falsetruetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 06230037 2020-04-01 2021-06-30 06230037 2019-04-01 2020-03-31 06230037 2021-06-30 06230037 2020-03-31 06230037 2019-04-01 06230037 c:Director2 2020-04-01 2021-06-30 06230037 d:Buildings d:ShortLeaseholdAssets 2020-04-01 2021-06-30 06230037 d:Buildings d:ShortLeaseholdAssets 2021-06-30 06230037 d:Buildings d:ShortLeaseholdAssets 2020-03-31 06230037 d:MotorVehicles 2020-04-01 2021-06-30 06230037 d:MotorVehicles 2021-06-30 06230037 d:MotorVehicles 2020-03-31 06230037 d:MotorVehicles d:OwnedOrFreeholdAssets 2020-04-01 2021-06-30 06230037 d:FurnitureFittings 2020-04-01 2021-06-30 06230037 d:FurnitureFittings 2021-06-30 06230037 d:FurnitureFittings 2020-03-31 06230037 d:FurnitureFittings d:OwnedOrFreeholdAssets 2020-04-01 2021-06-30 06230037 d:ComputerEquipment 2020-04-01 2021-06-30 06230037 d:ComputerEquipment 2021-06-30 06230037 d:ComputerEquipment 2020-03-31 06230037 d:ComputerEquipment d:OwnedOrFreeholdAssets 2020-04-01 2021-06-30 06230037 d:OwnedOrFreeholdAssets 2020-04-01 2021-06-30 06230037 d:CurrentFinancialInstruments 2021-06-30 06230037 d:CurrentFinancialInstruments 2020-03-31 06230037 d:CurrentFinancialInstruments d:WithinOneYear 2021-06-30 06230037 d:CurrentFinancialInstruments d:WithinOneYear 2020-03-31 06230037 d:ShareCapital 2021-06-30 06230037 d:ShareCapital 2020-03-31 06230037 d:RetainedEarningsAccumulatedLosses 2021-06-30 06230037 d:RetainedEarningsAccumulatedLosses 2020-03-31 06230037 c:OrdinaryShareClass1 2020-04-01 2021-06-30 06230037 c:OrdinaryShareClass1 2021-06-30 06230037 c:FRS102 2020-04-01 2021-06-30 06230037 c:AuditExempt-NoAccountantsReport 2020-04-01 2021-06-30 06230037 c:FullAccounts 2020-04-01 2021-06-30 06230037 c:PrivateLimitedCompanyLtd 2020-04-01 2021-06-30 06230037 d:WithinOneYear 2021-06-30 06230037 d:WithinOneYear 2020-03-31 06230037 d:BetweenOneFiveYears 2021-06-30 06230037 d:BetweenOneFiveYears 2020-03-31 06230037 2 2020-04-01 2021-06-30 06230037 d:AcceleratedTaxDepreciationDeferredTax 2021-06-30 06230037 d:AcceleratedTaxDepreciationDeferredTax 2020-03-31 06230037 d:OtherDeferredTax 2021-06-30 06230037 d:OtherDeferredTax 2020-03-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 06230037














PETTS WOOD PHARMACY LIMITED

 
UNAUDITED

FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 30 JUNE 2021

 
PETTS WOOD PHARMACY LIMITED
 

CONTENTS



Page
Balance sheet
 
1 - 2
Notes to the financial statements
 
3 - 10


 
PETTS WOOD PHARMACY LIMITED
REGISTERED NUMBER:06230037

BALANCE SHEET
AS AT 30 JUNE 2021

30 June
31 March
2021
2020
Note
£
£

Fixed assets
  

Tangible assets
 4 
22,718
30,379

  
22,718
30,379

Current assets
  

Stocks
 5 
246,772
203,709

Debtors: amounts falling due within one year
 6 
2,768,289
2,620,735

Cash at bank and in hand
 7 
2,106,567
1,412,101

  
5,121,628
4,236,545

Creditors: amounts falling due within one year
 8 
(595,686)
(497,697)

Net current assets
  
 
 
4,525,942
 
 
3,738,848

Total assets less current liabilities
  
4,548,660
3,769,227

Provisions for liabilities
  

Deferred tax
 9 
(1,862)
(2,117)

  
 
 
(1,862)
 
 
(2,117)

Net assets
  
4,546,798
3,767,110


Capital and reserves
  

Called up share capital 
 10 
4
4

Profit and loss account
  
4,546,794
3,767,106

  
4,546,798
3,767,110


1

 
PETTS WOOD PHARMACY LIMITED
REGISTERED NUMBER:06230037
    
BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2021

The director considers that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 12 January 2022.




G Dhillon
Director

The notes on pages 3 to 10 form part of these financial statements.

2

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2021

1.


General information

Petts Wood Pharmacy Limited is a private company, limited by shares, registered in England and Wales, registration number 06230037. The registered office address is Elsley Court, 20-22 Great Titchfield Street, London, W1W 8BE and the trading address is 83 Queensway, Petts Wood, Orpington, BR5 1DQ.
The principal activity of the company continued to be that of a pharmacy.
During the period, the company extended its accounting period from 31 March 2021 to 30 June 2021.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The company's functional and presentational currency is pound sterling.

The following principal accounting policies have been applied:

 
2.2

Going concern

The director is assessing, on a daily basis, the impact of the significant uncertainty arising from the COVID-19 virus. Whilst the director appreciates there is significant uncertainty surrounding the future economic climate, he considers the pharmaceutical industry to be particularly robust in this current situation and demand for the specific products the company supplies continues to increase. Despite the company experiencing what the director considers to be short term supply issues, the strong financial position of the company will allow time to determine and implement any changes required through decisions of director and the rising demand for company products is expected to realise turnover and profitability gains in the foreseeable future. The director is therefore satisfied that the company will be able to satisfy its financial obligations for at least 12 months from the date of signature of the financial statements, which have been prepared on the going concern basis.

 
2.3

Turnover

Turnover from pharmacy is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

3

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2021

2.Accounting policies (continued)


2.4
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method and on a reducing balance basis.

Depreciation is provided on the following basis:

Short term Leasehold Property
-
7%
on a straight line basis
Motor vehicles
-
25%
reducing balance basis
Fixtures and fittings
-
25%
reducing balance basis
Computer equipment
-
33%
on a straight line basis

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.5

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a weighted average basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.6

Debtors

Short term debtors are measured at transaction price, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

 
2.8

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties and loans to related parties.

 
2.9

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

4

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2021

2.Accounting policies (continued)

 
2.10

 Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Profit and loss account in the same period as the related expenditure.

 
2.11

 Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.12

 Operating leases: the company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the lease term.

 
2.13

 Pensions

Defined contribution pension plan

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the company in independently administered funds.

 
2.14

 Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.15

 Provisions for liabilities

Provisions are made where an event has taken place that gives the company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the company becomes aware of the obligation, and are measured at the best estimate at the Balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance sheet.

5

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2021

2.Accounting policies (continued)

 
2.16

 Current and deferred taxation

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current corporate tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


3.


Employees

The average monthly number of employees, including directors, during the period was 11 (2020 - 13).

6

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2021

4.


Tangible fixed assets







Short term Leasehold Property
Motor vehicles
Fixtures and fittings
Computer equipment
Total

£
£
£
£
£



Cost or valuation


At 1 April 2020
9,337
19,425
260,300
6,798
295,860


Additions
-
-
3,136
-
3,136


Disposals
-
-
(750)
-
(750)



At 30 June 2021

9,337
19,425
262,686
6,798
298,246



Depreciation


At 1 April 2020
7,621
14,029
237,033
6,798
265,481


Charge for the period on owned assets
778
1,686
8,017
-
10,481


Disposals
-
-
(434)
-
(434)



At 30 June 2021

8,399
15,715
244,616
6,798
275,528



Net book value



At 30 June 2021
938
3,710
18,070
-
22,718



At 31 March 2020
1,716
5,396
23,267
-
30,379




The net book value of land and buildings may be further analysed as follows:


30 June
31 March
2021
2020
£
£

Short leasehold
938
1,716



5.


Stocks

30 June
31 March
2021
2020
£
£

Finished goods and goods for resale
246,772
203,709


7

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2021

6.


Debtors

30 June
31 March
2021
2020
£
£


Trade debtors
379,992
212,670

Amounts owed by group undertakings
2,329,685
2,357,803

Other debtors
41,960
35,182

Prepayments
16,652
15,080

2,768,289
2,620,735



7.


Cash and cash equivalents

30 June
31 March
2021
2020
£
£

Cash at bank and in hand
2,106,567
1,412,101



8.


Creditors: Amounts falling due within one year

30 June
31 March
2021
2020
£
£

Trade creditors
273,259
341,579

Corporation tax
183,854
81,808

Other taxation and social security
-
901

Other creditors
119,686
55,620

Accruals
18,887
17,789

595,686
497,697




8

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2021

9.


Deferred taxation






2021
2020


£

£






At beginning of year
(2,117)
(2,957)


Charged to profit or loss
255
840



At end of year
(1,862)
(2,117)

The provision for deferred taxation is made up as follows:

30 June
31 March
2021
2020
£
£


Accelerated capital allowances
(2,152)
(2,223)

Short term timing differences
290
106

(1,862)
(2,117)


10.


Share capital

30 June
31 March
2021
2020
£
£
Allotted, called up and fully paid



4 Ordinary shares of £1.00 each
4
4



11.


Pension commitments

The company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £13,486 (2020 - £22,185). At the balance sheet date the company owed £435 (2020 - £557) to the pension fund. 

9

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2021

12.


Commitments under operating leases

At 30 June 2021 the company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

30 June
31 March
2021
2020
£
£


Not later than 1 year
18,500
18,500

Later than 1 year and not later than 5 years
9,250
32,375

27,750
50,875


13.


Related party transactions

At the period end, the company owed £26,094 (2020 - £45,690) to a director. This is an interest free loan and repayable on demand.
At the period end a director owed the company £6,595 (2020 - was owed £2,549). This loan is interest free and repayable on demand.
No disclosure has been made of transactions with other wholly owned group companies in accordance with FRS 102 section 1A paragraph 1AC.35, as the company is itself a wholly owned subsidiary of Interactive London Limited. 

 
10